Albany Molecular Research, EnzyMed Inc. deal

AMRI, a chemistry outsourcing company, will acquire EnzyMed, which markets its combinatorial biocatalysis platform for drug discovery applications, in a stock transaction valued at $20.6 million. AMRI...